170 related articles for article (PubMed ID: 9687405)
1. Pharmacokinetics of [18F]trovafloxacin in healthy human subjects studied with positron emission tomography.
Fischman AJ; Babich JW; Bonab AA; Alpert NM; Vincent J; Callahan RJ; Correia JA; Rubin RH
Antimicrob Agents Chemother; 1998 Aug; 42(8):2048-54. PubMed ID: 9687405
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of [18F]fleroxacin in healthy human subjects studied by using positron emission tomography.
Fischman AJ; Livni E; Babich J; Alpert NM; Liu YY; Thom E; Cleeland R; Prosser BL; Correia JA; Strauss HW
Antimicrob Agents Chemother; 1993 Oct; 37(10):2144-52. PubMed ID: 8257137
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of [18F]fleroxacin in patients with acute exacerbations of chronic bronchitis and complicated urinary tract infection studied by positron emission tomography.
Fischman AJ; Livni E; Babich JW; Alpert NM; Bonab A; Chodosh S; McGovern F; Kamitsuka P; Liu YY; Cleeland R; Prosser BL; Correia JA; Rubin RH
Antimicrob Agents Chemother; 1996 Mar; 40(3):659-64. PubMed ID: 8851589
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of 18F-labeled trovafloxacin in normal and Escherichia coli-infected rats and rabbits studied with positron emission tomography.
Fischman AJ; Babich JW; Alpert NM; Vincent J; Wilkinson RA; Callahan RJ; Correia JA; Rubin RH
Clin Microbiol Infect; 1997 Feb; 3(1):63-72. PubMed ID: 11864078
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and metabolism of single oral doses of trovafloxacin.
Vincent J; Teng R; Dalvie DK; Friedman HL
Am J Surg; 1998 Dec; 176(6A Suppl):8S-13S. PubMed ID: 9935250
[TBL] [Abstract][Full Text] [Related]
6. Trovafloxacin.
Haria M; Lamb HM
Drugs; 1997 Sep; 54(3):435-45; discussion 446. PubMed ID: 9279505
[TBL] [Abstract][Full Text] [Related]
7. Penetration of trovafloxacin into gynecologic tissues.
Martens MG; Maccato M; Van Hook C; Vincent J
Am J Surg; 1998 Dec; 176(6A Suppl):18S-22S. PubMed ID: 9935252
[TBL] [Abstract][Full Text] [Related]
8. Multiple-dose pharmacokinetics and safety of trovafloxacin in healthy volunteers.
Teng R; Liston TE; Harris SC
J Antimicrob Chemother; 1996 May; 37(5):955-63. PubMed ID: 8737145
[TBL] [Abstract][Full Text] [Related]
9. Hepatobiliary elimination of trovafloxacin and metabolites following single oral doses in healthy volunteers.
Melnik G; Schwesinger WH; Teng R; Dogolo LC; Vincent J
Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):424-6. PubMed ID: 9758286
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers.
Teng R; Harris SC; Nix DE; Schentag JJ; Foulds G; Liston TE
J Antimicrob Chemother; 1995 Aug; 36(2):385-94. PubMed ID: 8522468
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin.
Vincent J; Venitz J; Teng R; Baris BA; Willavize SA; Polzer RJ; Friedman HL
J Antimicrob Chemother; 1997 Jun; 39 Suppl B():75-80. PubMed ID: 9222074
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics of trovafloxacin, ofloxacin, and ciprofloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model.
Lister PD; Sanders CC
Antimicrob Agents Chemother; 1999 May; 43(5):1118-23. PubMed ID: 10223923
[TBL] [Abstract][Full Text] [Related]
13. Oral bioavailability of trovafloxacin with and without food in healthy volunteers.
Teng R; Dogolo LC; Willavize SA; Friedman HL; Vincent J
J Antimicrob Chemother; 1997 Jun; 39 Suppl B():87-92. PubMed ID: 9222076
[TBL] [Abstract][Full Text] [Related]
14. Activity of trovafloxacin (CP-99,219) against Legionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with L. pneumophila pneumonia.
Edelstein PH; Edelstein MA; Ren J; Polzer R; Gladue RP
Antimicrob Agents Chemother; 1996 Feb; 40(2):314-19. PubMed ID: 8834872
[TBL] [Abstract][Full Text] [Related]
15. Concentrations of trovafloxacin in colonic tissue and peritoneal fluid after intravenous infusion of the prodrug alatrofloxacin in patients undergoing colorectal surgery.
Melnik G; Schwesinger WH; Dogolo LC; Teng R; Vincent J
Am J Surg; 1998 Dec; 176(6A Suppl):14S-17S. PubMed ID: 9935251
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of 18F-labeled fleroxacin in rabbits with Escherichia coli infections, studied with positron emission tomography.
Fischman AJ; Livni E; Babich J; Alpert NM; Liu YY; Thom E; Cleeland R; Prosser BL; Callahan RJ; Correia JA
Antimicrob Agents Chemother; 1992 Oct; 36(10):2286-92. PubMed ID: 1444310
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics of trovafloxacin in a mouse model of cephalosporin-resistant Streptococcus pneumoniae pneumonia.
Ng W; Lutsar I; Wubbel L; Ghaffar F; Jafri H; McCracken GH; Friedland IR
J Antimicrob Chemother; 1999 Jun; 43(6):811-6. PubMed ID: 10404320
[TBL] [Abstract][Full Text] [Related]
18. Tissue pharmacokinetics of fleroxacin in humans as determined by positron emission tomography.
Rubin RH; Livni E; Babich J; Alpert NM; Liu YY; Cleeland R; Prosser BL; Thom E; Fischman AJ
Int J Antimicrob Agents; 1994 Jul; 4 Suppl 2():S15-20. PubMed ID: 18611628
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of a fluoronaphthyridone, trovafloxacin (CP 99,219), in infants and children following administration of a single intravenous dose of alatrofloxacin.
Bradley JS; Kearns GL; Reed MD; Capparelli EV; Vincent J
Antimicrob Agents Chemother; 2000 May; 44(5):1195-9. PubMed ID: 10770751
[TBL] [Abstract][Full Text] [Related]
20. Single- and multiple-dose administration, dosing regimens, and pharmacokinetics of trovafloxacin and alatrofloxacin in humans.
Vincent J; Dogolo L; Baris BA; Willavize SA; Teng R
Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):427-30. PubMed ID: 9758287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
